Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2

1(25.0%)

Early Phase 1

1(25.0%)

N/A

1(25.0%)

Phase 1

1(25.0%)

4Total

Phase 2(1)

Early Phase 1(1)

N/A(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07065968Phase 2Recruiting

The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

Role: collaborator

NCT05000372Phase 1Completed

68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

Role: collaborator

NCT04596670Early Phase 1Recruiting

68Ga-ICAM-1pep PET/CT in Cancer Patients

Role: collaborator

NCT03497780Terminated

Longitudinal Assessment of Cartilage Injury and Remodeling After Anterior Cruciate Ligament Rupture and Reconstruction:

Role: collaborator

NCT05204602Unknown

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Role: collaborator

NCT04257734Unknown

Epidemiologic and Clinical Characteristics of Optic Neuritis in China

Role: collaborator

NCT03401619Active Not Recruiting

Beijing Osteoporosis With Neurological Disorders in Epigenetic Changes Study

Role: collaborator

NCT04287712Completed

Detection of Lung Cancer by Plasma Lipids

Role: collaborator

NCT04156139Not ApplicableUnknown

HFNC vs NPPV After Early Extubation for Patients With COPD

Role: collaborator

NCT02569268Completed

Beijing Vascular Disease Patients Evaluation STudy

Role: collaborator

All 10 trials loaded